首页 | 本学科首页   官方微博 | 高级检索  
     

普伐他汀与多烯康治疗高脂血症的疗效比较
引用本文:陈寿生,王宇森,李瑞芬,胡铭芬,陈佳和,潘佩文. 普伐他汀与多烯康治疗高脂血症的疗效比较[J]. 中国新药与临床杂志, 1998, 17(5): 269-273
作者姓名:陈寿生  王宇森  李瑞芬  胡铭芬  陈佳和  潘佩文
作者单位:上海市卢湾区中心医院内科
摘    要:目的:比较普伐他汀与多烯康治疗高脂血症的疗效与安全性。方法:高脂血症60例,随机分为2组。普伐他汀组30例(男性16例,女性14例;年龄58±s11a)采用普伐他汀10~20mg,po,qn×6mo;多烯康组30例(男性18例,女性12例;年龄60±10a)采用多烯康胶丸3粒(0.45g/粒),po,tid×6mo。结果:普伐他汀组总胆固醇、三酰甘油、低密度脂蛋白胆固醇均显著下降(P<0.01),总有效率依次为90%,53%,93%;多烯康组下降均不显著;2组均无明显不良反应。结论:普伐他汀为一安全的、且降脂疗效优于多烯康的药物。

关 键 词:普伐他汀;多烯康;高脂血症;鱼油

Pravastatin vs Duo-xi-kang in treating hyperlipidemia
CHEN Shou_Sheng,WANG Yu_Sen,LI Rui_Fen,HU Ming_Fen,CHEN Jia_He,PAN Pei_Wen. Pravastatin vs Duo-xi-kang in treating hyperlipidemia[J]. Chinese Journal of New Drugs and Clinical Remedies, 1998, 17(5): 269-273
Authors:CHEN Shou_Sheng  WANG Yu_Sen  LI Rui_Fen  HU Ming_Fen  CHEN Jia_He  PAN Pei_Wen
Abstract:AIM: To compare the effects and safety of pravastatin and Duo_xi_kang in treating hyperlipidemia. METHODS: Hyperlipidemia 60 patients were randomly divided into 2 groups. Pravastatin group of 30 patients (M 16, F 14; age 58±s 11 a) received pravastatin 10_20 mg, po, qn for 6 mo. Duo_xi_kang group of 30 patients (M 18, F 12; age 60±10 a) received Duo_xi_kang 1.35 g(0.45 g/pill)po, tid for 6 mo. RESULTS: The total effective rates for reducing total cholesterol (TC), triglycerides (TG), and low_density lipoprotein cholesterol (LDL_ch) in pravastatin group were 90%, 53%, and 93%(P<0.01), respectively. Duo_xi_kang did not produce marked change. There were no severe adverse reactions. CONCLUSION: Pravastatin is safe and effective on hyperlipidemia.
Keywords:pravastatin  Duo_xi_kang  hyperlipidemia  fish oils  
本文献已被 CNKI 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号